5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid

C163H167F4N45O27S2 — CID 157454009

About 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid

5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid (PubChem CID 157454009) has the molecular formula C163H167F4N45O27S2 and a molecular weight of 3328.54 g/mol. Its IUPAC name is 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid.

Molecular Properties

• Compound Name: 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid
• PubChem CID: 157454009
• Molecular Formula: C163H167F4N45O27S2
• Molecular Weight: 3328.54 g/mol
• Exact Mass: 3326.25
• IUPAC Name: 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid
• SMILES: CC(=O)c1cccc(F)c1-n1nnn(C(=O)N(c2ccc(C)c(C(=O)OCc3ccccc3)c2)C(C)C)c1=O.COc1ccc(N(C(=O)n2nnn(-c3cccc4nsnc34)c2=O)C2CCCCC2)cc1C.Cc1ccc(N(C(=O)n2nnn(-c3c(F)cccc3F)c2=O)C2CCCCC2)cn1.Cc1ccc(N(C(=O)n2nnn(-c3c(F)cccc3N3CCOCC3)c2=O)C2CCCCC2)cc1C(=O)O.Cc1ccc(N(C(=O)n2nnn(-c3cccc(N)c3N)c2=O)C2CCCCC2)cc1C(=O)O.Cc1ccc(N(C(=O)n2nnn(-c3cccc4[nH]cnc34)c2=O)C2CCCCC2)cc1C(=O)O.Cc1ccc(N(C(=O)n2nnn(-c3cccc4nsnc34)c2=O)C2CCCCC2)cc1C(=O)O
• InChI: InChI=1S/C28H26FN5O5.C26H29FN6O5.C23H23N7O4.C22H21N7O4S.C22H25N7O4.C22H23N7O3S.C20H20F2N6O2/c1-17(2)32(21-14-13-18(3)23(15-21)26(36)39-16-20-9-6-5-7-10-20)27(37)34-28(38)33(30-31-34)25-22(19(4)35)11-8-12-24(25)29;1-17-10-11-19(16-20(17)24(34)35)31(18-6-3-2-4-7-18)25(36)33-26(37)32(28-29-33)23-21(27)8-5-9-22(23)30-12-14-38-15-13-30;1-14-10-11-16(12-17(14)21(31)32)28(15-6-3-2-4-7-15)22(33)30-23(34)29(26-27-30)19-9-5-8-18-20(19)25-13-24-18;1-13-10-11-15(12-16(13)20(30)31)27(14-6-3-2-4-7-14)21(32)29-22(33)28(25-26-29)18-9-5-8-17-19(18)24-34-23-17;1-13-10-11-15(12-16(13)20(30)31)27(14-6-3-2-4-7-14)21(32)29-22(33)28(25-26-29)18-9-5-8-17(23)19(18)24;1-14-13-16(11-12-19(14)32-2)27(15-7-4-3-5-8-15)21(30)29-22(31)28(25-26-29)18-10-6-9-17-20(18)24-33-23-17;1-13-10-11-15(12-23-13)26(14-6-3-2-4-7-14)19(29)28-20(30)27(24-25-28)18-16(21)8-5-9-17(18)22/h5-15,17H,16H2,1-4H3;5,8-11,16,18H,2-4,6-7,12-15H2,1H3,(H,34,35);5,8-13,15H,2-4,6-7H2,1H3,(H,24,25)(H,31,32);5,8-12,14H,2-4,6-7H2,1H3,(H,30,31);5,8-12,14H,2-4,6-7,23-24H2,1H3,(H,30,31);6,9-13,15H,3-5,7-8H2,1-2H3;5,8-12,14H,2-4,6-7H2,1H3
• InChIKey: BTDDULLATOMYNP-UHFFFAOYSA-N
• XLogP: 23.09
• TPSA: 870.58 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 62
• Rotatable Bonds: 31
• Heavy Atoms: 241
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3328.54
LogP ≤ 5	23.09
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	62

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'amidotetrazole', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid?

The IUPAC name of 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid (CID 157454009) is 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid.

What is the SMILES notation for 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid?

The canonical SMILES for 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid is CC(=O)c1cccc(F)c1-n1nnn(C(=O)N(c2ccc(C)c(C(=O)OCc3ccccc3)c2)C(C)C)c1=O.COc1ccc(N(C(=O)n2nnn(-c3cccc4nsnc34)c2=O)C2CCCCC2)cc1C.Cc1ccc(N(C(=O)n2nnn(-c3c(F)cccc3F)c2=O)C2CCCCC2)cn1.Cc1ccc(N(C(=O)n2nnn(-c3c(F)cccc3N3CCOCC3)c2=O)C2CCCCC2)cc1C(=O)O.Cc1ccc(N(C(=O)n2nnn(-c3cccc(N)c3N)c2=O)C2CCCCC2)cc1C(=O)O.Cc1ccc(N(C(=O)n2nnn(-c3cccc4[nH]cnc34)c2=O)C2CCCCC2)cc1C(=O)O.Cc1ccc(N(C(=O)n2nnn(-c3cccc4nsnc34)c2=O)C2CCCCC2)cc1C(=O)O.

What is the InChIKey of 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid?

The InChIKey is BTDDULLATOMYNP-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26FN5O5.C26H29FN6O5.C23H23N7O4.C22H21N7O4S.C22H25N7O4.C22H23N7O3S.C20H20F2N6O2/c1-17(2)32(21-14-13-18(3)23(15-21)26(36)39-16-20-9-6-5-7-10-20)27(37)34-28(38)33(30-31-34)25-22(19(4)35)11-8-12-24(25)29;1-17-10-11-19(16-20(17)24(34)35)31(18-6-3-2-4-7-18)25(36)33-26(37)32(28-29-33)23-21(27)8-5-9-22(23)30-12-14-38-15-13-30;1-14-10-11-16(12-17(14)21(31)32)28(15-6-3-2-4-7-15)22(33)30-23(34)29(26-27-30)19-9-5-8-18-20(19)25-13-24-18;1-13-10-11-15(12-16(13)20(30)31)27(14-6-3-2-4-7-14)21(32)29-22(33)28(25-26-29)18-9-5-8-17-19(18)24-34-23-17;1-13-10-11-15(12-16(13)20(30)31)27(14-6-3-2-4-7-14)21(32)29-22(33)28(25-26-29)18-9-5-8-17(23)19(18)24;1-14-13-16(11-12-19(14)32-2)27(15-7-4-3-5-8-15)21(30)29-22(31)28(25-26-29)18-10-6-9-17-20(18)24-33-23-17;1-13-10-11-15(12-23-13)26(14-6-3-2-4-7-14)19(29)28-20(30)27(24-25-28)18-16(21)8-5-9-17(18)22/h5-15,17H,16H2,1-4H3;5,8-11,16,18H,2-4,6-7,12-15H2,1H3,(H,34,35);5,8-13,15H,2-4,6-7H2,1H3,(H,24,25)(H,31,32);5,8-12,14H,2-4,6-7H2,1H3,(H,30,31);5,8-12,14H,2-4,6-7,23-24H2,1H3,(H,30,31);6,9-13,15H,3-5,7-8H2,1-2H3;5,8-12,14H,2-4,6-7H2,1H3.

What are the key properties of 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid?

5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid has a molecular weight of 3328.54 g/mol, XLogP of 23.09, 31 rotatable bonds, 7 hydrogen bond donors, and 62 hydrogen bond acceptors.

Where does this data come from?

All data for 5-[[4-(1H-benzimidazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;4-(2,1,3-benzothiadiazol-4-yl)-N-cyclohexyl-N-(4-methoxy-3-methylphenyl)-5-oxotetrazole-1-carboxamide;5-[[4-(2,1,3-benzothiadiazol-4-yl)-5-oxotetrazole-1-carbonyl]-cyclohexylamino]-2-methylbenzoic acid;benzyl 5-[[4-(2-acetyl-6-fluorophenyl)-5-oxotetrazole-1-carbonyl]-propan-2-ylamino]-2-methylbenzoate;5-[cyclohexyl-[4-(2,3-diaminophenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid;N-cyclohexyl-4-(2,6-difluorophenyl)-N-(6-methyl-3-pyridinyl)-5-oxotetrazole-1-carboxamide;5-[cyclohexyl-[4-(2-fluoro-6-morpholin-4-ylphenyl)-5-oxotetrazole-1-carbonyl]amino]-2-methylbenzoic acid is sourced from PubChem (CID 157454009), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).